Aspira Womens Health Inc. buy krebskrebs
Start price
24.01.22
/
50%
€14.78
Target price
24.01.23
€24.00
Performance (%)
-57.36%
End price
25.01.23
€6.30
Summary
This prediction ended on 25.01.23 with a price of €6.30. Massive losses of -57.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
Comments by krebskrebs for this prediction
In the thread Vermillion Inc. diskutieren
Buy mit Kursziel 1,6
In the thread Trading Vermillion Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

